Table 1 Demographic characteristics of the volunteers enrolled in the study
BD (n = 24) | SZ (n = 24) | HG (n = 46) | |
|---|---|---|---|
Sex F/M | 21/03 | 07/17 | 43/03 |
Age (mean and SD) | 41 ± 13,1 | 42 ± 13,5 | 41,77 ± 7,2 |
MADRS (mean and SD) | 14 ± 4 | Not applicable | Not applicable |
YOUNG (mean and SD) | 6 ± 2 | Not applicable | Not applicable |
Employment status (n/%) | Yes (10/41.6) No (14/58.3) | Yes (01/4.1) No (23/95.9) | Yes (43/93.5) No (03/6.5) |
Medications related to MD (n/%) | Alprazolam (1/4.1) Biperiden (1/4.1) Carbamazepine (2/8.3) Lithium carbonate (11/45.8) Chlorpromazine (2/8.3) Diazepam (1/4.1) Fluoxetine (1/4.1) Haloperidol (1/4.1) Lurasidone (1/4.1) Pregabalin (1/4.1) Quetiapine (3/12.5) Rispiridone (8/33.3) Sodium volproate (9/37.5) | Biperiden (4/16.6) Lithium carbonate (2/8.3) Clonazepam (3/12.5) Fluoxetine (4/16.6) Chlorpromazine (3/12.5) Clozapine (1/4.1) Haloperidol (3/12.5) Olanzapine (1/4.1) Rispiridone (7/29.1) Sodium volprate (4/16.6) | Not applicable |
Family history of MD (n/%) | Yes (14/58.3) No (10/41.7) | Yes (11/45.3) No (13/54.7) | Yes (0/0) No (46/100) |